Hear AtLast Holdings, Inc. (HRAL)
USD 0.0
(25.0%)
USD 0.0
(25.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 109.93 Thousand USD | 5.39% |
| 2022 | 104.31 Thousand USD | -37.76% |
| 2021 | 167.58 Thousand USD | -48.84% |
| 2020 | 327.53 Thousand USD | -59.62% |
| 2019 | 811.1 Thousand USD | 26936.67% |
| 2018 | 3000.00 USD | 0.0% |
| 2017 | - USD | 0.0% |
| 2016 | - USD | 0.0% |
| 2015 | - USD | -100.0% |
| 2014 | 1.07 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 42.68 Thousand USD | 24.64% |
| 2023 Q4 | 34.25 Thousand USD | 49.49% |
| 2023 FY | 109.93 Thousand USD | 5.39% |
| 2023 Q3 | 22.91 Thousand USD | -29.61% |
| 2023 Q2 | 32.54 Thousand USD | 60.97% |
| 2023 Q1 | 20.22 Thousand USD | -8.79% |
| 2022 Q4 | 22.16 Thousand USD | 10.05% |
| 2022 Q3 | 20.14 Thousand USD | -66.47% |
| 2022 Q1 | 1910.00 USD | -97.27% |
| 2022 FY | 104.31 Thousand USD | -37.76% |
| 2022 Q2 | 60.08 Thousand USD | 3045.86% |
| 2021 Q3 | 19.75 Thousand USD | -12.82% |
| 2021 Q4 | 69.87 Thousand USD | 253.74% |
| 2021 Q2 | 22.65 Thousand USD | 45.27% |
| 2021 Q1 | 15.59 Thousand USD | 68.31% |
| 2021 FY | 167.58 Thousand USD | -48.84% |
| 2020 Q2 | 289.49 Thousand USD | 1788.29% |
| 2020 Q3 | 13.44 Thousand USD | -95.36% |
| 2020 Q4 | 9267.00 USD | -31.06% |
| 2020 Q1 | 15.33 Thousand USD | -97.24% |
| 2020 FY | 327.53 Thousand USD | -59.62% |
| 2019 Q4 | 556.15 Thousand USD | 736.32% |
| 2019 FY | 811.1 Thousand USD | 26936.67% |
| 2019 Q2 | 87.61 Thousand USD | -13.1% |
| 2019 Q1 | 100.83 Thousand USD | -51.2% |
| 2019 Q3 | 66.5 Thousand USD | -24.1% |
| 2018 FY | 3000.00 USD | 0.0% |
| 2018 Q4 | 206.61 Thousand USD | 27449.07% |
| 2018 Q2 | 1500.00 USD | 0.0% |
| 2018 Q3 | 750.00 USD | -50.0% |
| 2017 FY | - USD | 0.0% |
| 2016 FY | - USD | 0.0% |
| 2015 FY | - USD | -100.0% |
| 2014 FY | 1.07 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| American Medical Technologies Inc. | 2.86 Million USD | 96.161% |
| Ansell Limited | 495.5 Million USD | 99.978% |
| Ansell Limited | 495.5 Million USD | 99.978% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 82.8 Million USD | 99.867% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 1.73 Million USD | 93.648% |
| Psykey, Inc. | 1.21 Million USD | 90.941% |
| ConvaTec Group Plc | 910.31 Million USD | 99.988% |
| ConvaTec Group Plc | 872.5 Million USD | 99.987% |
| Encision Inc. | 3.77 Million USD | 97.089% |
| Golden Valley Development, Inc | 141.81 Thousand USD | 22.481% |
| Innovative MedTech Inc. | 6.09 Million USD | 98.198% |
| LifePoint, Inc. | 7.42 Million USD | 98.519% |
| Medite Cancer Diagnostics, Inc. | 6.34 Million USD | 98.269% |
| Paradigm Medical Industries, Inc. | 855 Thousand USD | 87.143% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 726.13 Thousand USD | 84.861% |
| Reflect Scientific, Inc. | 1.06 Million USD | 89.665% |
| SmileDirectClub, Inc. | 517 Million USD | 99.979% |
| Sector 10, Inc. | 39.84 Thousand USD | -175.904% |
| Shandong Weigao Group Medical Polymer Company Limited | 6.64 Billion USD | 99.998% |
| SheerVision, Inc. | 2.33 Million USD | 95.285% |
| United Health Products, Inc. | 2.42 Million USD | 95.47% |
| Vasamed, Inc. | 4.67 Million USD | 97.647% |
| Wearable Health Solutions, Inc. | 2.56 Million USD | 95.709% |
| Yubo International Biotech Limited | 1.25 Million USD | 91.261% |